Clinical Trials · NCT02611232
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- University of Oulu
- Enrollment
- 42
- Start date
- Dec 2015
- Locations
- 3 sites, Finland
- Primary endpoint
- FPIR (first phase insulin response)